THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN DIABETIC-PATIENTS WITH HYPERKALEMIA

被引：18
|
作者：
SUNDERLIN, FS [1 ]
ANDERSON, GH [1 ]
STREETEN, DHP [1 ]
BLUMENTHAL, SA [1 ]
机构：
[1] SUNY UPSTATE MED CTR,DEPT MED,ENDOCRINOL SECT,SYRACUSE,NY 13210
来源：
DIABETES | 1981年 / 30卷 / 04期
关键词：
D O I：
10.2337/diabetes.30.4.335
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：335 / 340
页数：6
相关论文
共 50 条
  • [1] Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system
    Segal, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23): : 2450 - 2451
  • [2] EFFECT OF NIFEDIPINE ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND RENAL PROSTAGLANDINS IN DIABETIC-PATIENTS
    KOEV, D
    ZACHARIEVA, S
    TCHARAKTCHIEV, D
    BORISSOVA, AM
    ANDONOVA, K
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1989, 12 (02): : 63 - 65
  • [3] Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system - Reply
    Palmer, BF
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23): : 2451 - 2451
  • [4] Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
    Palmer, BF
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06): : 585 - 592
  • [5] Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors
    De Nicola, Luca
    Ferraro, Pietro Manuel
    Montagnani, Andrea
    Pontremoli, Roberto
    Dentali, Francesco
    Sesti, Giorgio
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (02) : 295 - 306
  • [6] Prevention and management of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors
    Weinstein, Jordan
    Girard, Louis-Philippe
    Lepage, Serge
    McKelvie, Robert S.
    Tennankore, Karthik
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (48) : E1836 - E1841
  • [7] The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
    Hollenberg, NK
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 : S185 - S187
  • [8] Dual blockade of the renin-angiotensin-aldosterone system in patients with diabetic nephropathy
    Bogaert, Yolanda E.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (10): : 532 - 533
  • [9] Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors: comment
    Ozdede, Murat
    Guven, Alper Tuna
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (03) : 879 - 881
  • [10] RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN MILD DIABETIC NEPHROPATHY
    TOMITA, K
    MATSUDA, O
    IDEURA, T
    SHIIGAI, T
    TAKEUCHI, J
    NEPHRON, 1982, 31 (04): : 361 - 367
12345